WiseGuyRerports.com Presents “Global Colorectal Cancer Market Size, Status and Forecast 2018-2025” New Document to its Studies Database
Colorectal cancer is a type of cancer, which develops from rectum or colon, so it is also known as colon cancer and bowel cancer. Bowel cancer starts from the large intestine region, which is in the lower part of the digestive system. The initial phase of Colorectal Cancer is called adenomatous polyps, where it started to develop small clusters of cells in the intestine. If adenomatous polyps are not treated properly, it will result in bowel cancer. So, it is always recommended to screen the adenomatous polyps regularly to prevent cancer.
Blood in stool and changing bowel habits are the basic symptoms of Bowel cancer. Bowel cancer is extensively seen in countries like the United States. According to a study, bowel cancer is the third most diagnosed cancer while it stands at number two in terms of leading to cancer in the United States.
The increasing number of incidences and the heavy pricing of drugs attracted pharmaceutical companies to invest in this sector. Even some surveys stated that the cost-benefit ratio of Bowel cancer is highest in the industry. Extensive research and development are expected to reduce the cost of the treatment and make the drugs accessible to everyone. Diarrhea, loss of appetite, a lump in the back passage, pain in the abdomen, blood in feces, blood in feces, vomiting, fatigue, constipation, loss of weight, vomiting, fatigue, nausea, and iron deficiency are some of the symptoms associated with Colorectal Cancer.
According to a study, the Colorectal Cancer drug market is anticipated to reach 10.8 billion by 2022. The industry is expected to show an impressive Compound Annual Growth Rate (CAGR) of 3.3% by 2022.
Major Key Players:
Market Segmentation of Global Colorectal Cancer Market
The global Colorectal Cancer market can be divided into by Type, Application, and Region.
Based on Type, the market is divided into Microscopy, Macroscopy, Tumor Budding, Staging, and Immunochemistry.
Based on Application, the global market can be segmented into Clinics, Hospitals, Ambulatory Surgical Centers, and Others. Among them, the Hospital covered the largest market share and expected to show the largest Compound Annual Growth Rate (CAGR) during the forecast period.
Segmentation of Global Colorectal Cancer Market
The geographical Colorectal Cancer market includes regions like Canada, Mexico, Russia, Spain, the Middle East, Africa, Japan, Korea, Southeast Asia, South Africa, Israel, Turkey, the United States, Brazil, Australia, India, Europe, Germany, the UK, Italy, Egypt, GCC Countries, APAC, China, and France.
The North American region is leading the chart owing to a large number of cases found in the region and significantly higher spending on research and development. The region is anticipated to grow during the forecast period, as well.
Current News from Global Colorectal Cancer Market
In a recent research report published by The Journal of Medical Screening said that the chances of colon cancer for the people in their 40s increased by 1.3% every year since 1995. But in good part, people above 55 have seen a decreased number of Bowel Cancer. Child obesity is the major reason behind the increased number. People who were overweight in their childhood most likely to be affected by the disease in the latter half of their life.
Table Of Content:
1 Market Overview
2 Global Market Competition by Manufacturers
3 Global Capacity, Production, Revenue (Value) by Region (2013-2018)
4 Global Supply (Production), Consumption, Export, Import by Region (2013-2018)
5 Global Production, Revenue (Value), Price Trend by Type
6 Global Market Analysis by Application
7 Global Manufacturers Profiles/Analysis
8 Manufacturing Cost Analysis
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
11 Market Effect Factors Analysis
12 Global Market Forecast (2018-2025)
13 Research Findings and Conclusion
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)